ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

September 19, 2022

https://www.globenewswire.com/news-release/2022/09/19/2518720/25687/en/ClearPoint-Neuro-Announces-FDA-Clearance-for-Software-Version-2-1.html

SOLANA BEACH, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has obtained 510(k) clearance for version 2.1 of the ClearPoint Neuro Navigation software.

Read more at globenewswire.com

Related news for (CLPT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.